'Significant milestone' as STARLIMS acquires Labstep to unlock lab data's full potential

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags Lab research R&D electronic lab notebook

STARLIMS, a company that provides enterprise informatics solutions has acquired Labstep, a research and development (R&D) electronic laboratory notebook (ELN).

The companies believe the acquisition will address critical challenges customers face in finding an advanced platform to support to support them from R&D through to market surveillance.

They said combining STARLIMS’ laboratory information management system (LIMS) technology with Labstep’s SaaS ELN platform users can remove the difficulty from the lab and unlock their data’s full potential in a progressive, connected system.

The acquisition of Labstep represents a significant milestone STARLIMS says, as it introduces a ‘modern and user-friendly ELN to its existing platform’.

Benefits of the integration include accelerating ideation and planning through easy-to-use documentation functionality, automation capabilities, and seamless connectivity to instruments and systems, moving users away from cumbersome paper-based record keeping.

STARLIMS said the unified solution will liberate scientists from manual documentation, leaving them with more time to conduct research.

“We are thrilled to bring Labstep into our portfolio. Labstep's high-caliber team, coupled with its forward-thinking approach to addressing industry challenges, makes it an excellent addition to STARLIMS," said Trey Cook, CEO at STARLIMS.

"Their user-centric approach has resulted in an intuitive ELN for science that allows research and development teams to increase the speed of ideation and new product introduction, while giving them a modern, simplified experience.”

Labstep states its ELN uses interactive, step-by-step protocols as templates for data collection to ensure continuous data capture for researchers. The solution was created by a team of scientists, for scientists, with the goal of building a progressive operating system that reflects the needs of the modern R&D lab.

Jake Schofield, CEO & founder at Labstep, said: “We’re excited to be joining the STARLIMS’ team and its robust set of solutions. As a recognized leader in LIMS technology, it was a natural next step for us to take Labstep to the next level.

“Together, our solutions create a connected platform that not only accelerates R&D, but also supports the product throughout its entire lifecycle. The mission to simplify workflows and enhance productivity will ultimately advance scientific discovery, and help companies bring innovative, quality products to market faster.”

Related news

Show more

Related products

show more

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more